Sonomind provides a new treatment method for psychiatric disorders like depression, anxiety, and addiction.
Sonomind has raised $23.5M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
Sonomind's investors include Bpifrance, AGORANOV, Critical Path Ventures.
Sonomind is headquartered in Paris, France.
Sonomind provides a new treatment method for psychiatric disorders like depression, anxiety, and addiction.
Sonomind is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sonomind — Funding & Investors." VCBacked, May 12, 2026, https://www.vcbacked.co/company/sonomind. Accessed July 24, 2026.
VCBacked. (2026). Sonomind — Funding & Investors. Retrieved July 24, 2026, from https://www.vcbacked.co/company/sonomind
{{cite web |title=Sonomind — Funding & Investors |url=https://www.vcbacked.co/company/sonomind |website=VCBacked |access-date=July 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated